Literature DB >> 807983

Neutrophil function in clinical kidney allograft recipients.

J B Grogan, G V Smith.   

Abstract

The peripheral blood neutrophils from 17 kidney transplant recipients were studied for their ability to phagocytose and kill Pseudomonas aeruginosa in vitro. Practically all of the percent phagocytosis values were within the normal range but many of the neutrophil samples demonstrated a reduced ability to kill ingested P. aeruginosa, particularly within the 3 month period immediately after transplant. Of the 17 patients studied, ten were found to have neutrophils with a reduced capacity to kill the test bacteria. These defects in bactericidal capacity were found in patients who received antihuman-lymphocyte globulin (ALG), large doses of methylprednisolone for rejection, and mostly in subclinical infection with Pseudomonas or other gram-negative bacterial species.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 807983

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  4 in total

1.  Human Neutrophils Are Primed by Chemoattractant Gradients for Blocking the Growth of Aspergillus fumigatus.

Authors:  Caroline N Jones; Laurie Dimisko; Kevin Forrest; Kevin Judice; Mark C Poznansky; James F Markmann; Jatin M Vyas; Daniel Irimia
Journal:  J Infect Dis       Date:  2015-08-12       Impact factor: 5.226

2.  Defective neutrophil chemotaxis in bone marrow transplant patients.

Authors:  R A Clark; F L Johnson; S J Klebanoff; E D Thomas
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

3.  The effects on polymorphonuclear leucocyte function of prednisolone and azathioprine in vivo and prednisolone, azathioprine and 6-mercaptopurine in vitro.

Authors:  A Losito; D G Williams; G Cooke; L Harris
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

4.  [Peritonitis following kidney transplantation].

Authors:  T Hau; M F Mozes; O Jonasson
Journal:  Langenbecks Arch Chir       Date:  1981
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.